Key result
Prehospital thrombolysis for STEMI cuts FMC-to-needle time by ~59 minutes versus in-hospital baseline.
Why the study?
Time to treatment in STEMI directly impacts morbidity and mortality, prompting the use of prehospital thrombolysis to reduce time from first medical contact to treatment where transport times to PCI centres are prolonged.
Does prehospital thrombolysis administered by paramedics reduce time from first medical contact to treatment in STEMI patients?
Does prehospital thrombolysis administered by paramedics reduce time from first medical contact to treatment in STEMI patients?
A quality improvement initiative implementing prehospital thrombolysis by paramedics with remote cardiologist support significantly reduced time to treatment and acute care costs for STEMI patients.
Answers are grounded in this paper and cite their sources.
Supports shorter STEMI treatment times with prehospital thrombolysis; leaves open outcome benefits in randomized trials.
Coronary artery disease is the second leading cause of death in Canada. Time to treatment in ST-elevation myocardial infarction (STEMI) is directly related to morbidity and mortality. Thrombolysis is the primary treatment for STEMI in many regions of Canada because of prolonged transport times to percutaneous coronary intervention-capable centres. To reduce time from first medical contact (FMC) to thrombolysis, some emergency medical services (EMS) systems have implemented prehospital thrombolysis (PHT). PHT is not a novel concept and has a strong evidence base showing reduced mortality.Here, we describe a quality improvement initiative to decrease time from FMC to thrombolysis using PHT and aim to describe our methods and challenges during implementation. We used a quality improvement framework to collaborate with hospitals, EMS, cardiology, emergency medicine and other stakeholders during implementation. We trained advanced care paramedics to administer thrombolysis in STEMI with remote cardiologist support and aimed to achieve a guideline-recommended median FMC to needle time of <30 min in 80% of patients.Overall, we reduced our median FMC to needle time by 70%. Our baseline patients undergoing in-hospital thrombolysis had a median time of 84 min (IQR 62-116 min), while patients after implementation of PHT had a median time of 25 min (IQR 23-39 min). Patients treated within the guideline-recommended time from FMC to needle of <30 min increased from 0% at baseline to 61% with PHT. Return on investment analysis showed $2.80 saved in acute care costs for every $1.00 spent on the intervention.While we did not achieve our goal of 80% compliance with FMC to needle time of <30 min, our results show that the intervention substantially reduced the FMC to needle time and overall cost. We plan to continue with ongoing implementation of PHT through expansion to other communities in our province.
No takes yet. Share an insight, caveat, or question.
Guy et al. (2021) studied ST-elevation myocardial infarction (STEMI). Prehospital thrombolysis (PHT) vs. In-hospital thrombolysis was evaluated on Median time from first medical contact (FMC) to thrombolysis (needle time) in minutes. Prehospital thrombolysis for STEMI reduced median first medical contact to needle time from 84 minutes to 25 minutes compared to baseline in-hospital thrombolysis.
Synapse has enriched 10 related papers. Consider them for comparative context: